PYC Therapeutics Limited (PYC.AX)
AUD 1.0
(2.04%)
AUD 1.0
(2.04%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | -17.99 Million AUD | 0.0% |
| 2023 | - AUD | 0.0% |
| 2022 | - AUD | 0.0% |
| 2021 | - AUD | 0.0% |
| 2020 | - AUD | 100.0% |
| 2019 | -10.82 Thousand AUD | 0.0% |
| 2018 | - AUD | 100.0% |
| 2017 | -192.2 Thousand AUD | -52.96% |
| 2016 | -125.65 Thousand AUD | -5.19% |
| 2015 | -119.45 Thousand AUD | 30.69% |
| 2014 | -172.34 Thousand AUD | -45.2% |
| 2013 | -118.69 Thousand AUD | 0.0% |
| 2012 | - AUD | 0.0% |
| 2011 | - AUD | 0.0% |
| 2010 | - AUD | 0.0% |
| 2009 | - AUD | 0.0% |
| 2008 | - AUD | 0.0% |
| 2007 | - AUD | 0.0% |
| 2006 | - AUD | 0.0% |
| 2005 | - AUD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 1.00 AUD | 0.0% |
| 2024 Q4 | -17.99 Million AUD | 0.0% |
| 2024 FY | - AUD | 0.0% |
| 2023 FY | - AUD | 0.0% |
| 2023 Q4 | - AUD | 0.0% |
| 2023 Q2 | 1.00 AUD | 0.0% |
| 2022 Q2 | 1.00 AUD | 0.0% |
| 2022 Q4 | - AUD | 0.0% |
| 2022 FY | - AUD | 0.0% |
| 2021 Q4 | - AUD | 0.0% |
| 2021 Q2 | - AUD | 0.0% |
| 2021 FY | - AUD | 0.0% |
| 2020 Q2 | - AUD | 0.0% |
| 2020 FY | - AUD | 100.0% |
| 2020 Q4 | - AUD | 0.0% |
| 2019 Q4 | -10.82 Thousand AUD | 0.0% |
| 2019 Q2 | - AUD | 0.0% |
| 2019 FY | -10.82 Thousand AUD | 0.0% |
| 2018 Q4 | - AUD | 0.0% |
| 2018 FY | - AUD | 100.0% |
| 2018 Q2 | - AUD | 0.0% |
| 2017 Q4 | -192.2 Thousand AUD | 0.0% |
| 2017 Q2 | 1.00 AUD | 0.0% |
| 2017 FY | -192.2 Thousand AUD | -52.96% |
| 2016 FY | -125.65 Thousand AUD | -5.19% |
| 2016 Q4 | -125.65 Thousand AUD | 0.0% |
| 2016 Q2 | - AUD | 0.0% |
| 2015 FY | -119.45 Thousand AUD | 30.69% |
| 2015 Q4 | -119.45 Thousand AUD | 0.0% |
| 2015 Q2 | - AUD | 0.0% |
| 2014 FY | -172.34 Thousand AUD | -45.2% |
| 2014 Q4 | -172.34 Thousand AUD | 0.0% |
| 2014 Q2 | - AUD | 0.0% |
| 2013 Q1 | - AUD | 0.0% |
| 2013 FY | -118.69 Thousand AUD | 0.0% |
| 2013 Q4 | -118.69 Thousand AUD | 0.0% |
| 2013 Q3 | - AUD | 0.0% |
| 2013 Q2 | - AUD | 0.0% |
| 2012 FY | - AUD | 0.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2011 FY | - AUD | 0.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2010 Q4 | - AUD | 0.0% |
| 2010 FY | - AUD | 0.0% |
| 2009 FY | - AUD | 0.0% |
| 2009 Q4 | - AUD | 0.0% |
| 2008 Q4 | - AUD | 0.0% |
| 2008 FY | - AUD | 0.0% |
| 2007 Q4 | - AUD | 0.0% |
| 2007 FY | - AUD | 0.0% |
| 2006 FY | - AUD | 0.0% |
| 2006 Q4 | - AUD | 0.0% |
| 2005 FY | - AUD | 0.0% |
| 2005 Q4 | - AUD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| AdAlta Limited | -1.67 Million AUD | -971.493% |
| Biome Australia Limited | 1.88 Million AUD | 1052.885% |
| Radiopharm Theranostics Limited | -987.41 Thousand AUD | -1722.537% |
| Biotron Limited | - AUD | Infinity% |
| Acrux Limited | 147 Thousand AUD | 12342.153% |
| Alterity Therapeutics Limited | 1.00 AUD | 1799596600.0% |
| Botanix Pharmaceuticals Limited | 1.2 Million AUD | 1588.04% |
| BTC Health Limited | - AUD | Infinity% |
| Chimeric Therapeutics Limited | - AUD | Infinity% |
| CSL Limited | 8.93 Billion AUD | 100.202% |
| Clarity Pharmaceuticals Ltd | - AUD | Infinity% |
| Clinuvel Pharmaceuticals Limited | 10.62 Million AUD | 269.348% |
| Immutep Limited | 2.00 AUD | 899798350.0% |
| Memphasys Limited | 164.76 Thousand AUD | 11022.466% |
| Neuren Pharmaceuticals Limited | - AUD | Infinity% |
| Noxopharm Limited | -2.35 Million AUD | -662.786% |
| Prescient Therapeutics Limited | - AUD | Infinity% |
| Race Oncology Limited | 16.4 Thousand AUD | 109824.803% |
| Starpharma Holdings Limited | 2.4 Million AUD | 847.341% |
| Tissue Repair Ltd | 214.72 Thousand AUD | 8481.053% |
| EZZ Life Science Holdings Limited | 1.4 Million AUD | 1384.33% |
| Anatara Lifesciences Ltd | -671.09 Thousand AUD | -2581.594% |
| Bio-Gene Technology Limited | - AUD | Infinity% |
| Zelira Therapeutics Limited | 1.25 Million AUD | 1537.02% |
| Patrys Limited | - AUD | Infinity% |
| Orthocell Limited | 1.17 Million AUD | 1629.439% |
| Imugene Limited | - AUD | Infinity% |
| Proteomics International Laboratories Limited | - AUD | Infinity% |
| Cynata Therapeutics Limited | 108.2 Thousand AUD | 16731.515% |
| Arovella Therapeutics Limited | - AUD | Infinity% |
| Nanollose Limited | - AUD | Infinity% |
| Invex Therapeutics Ltd | -94.98 Thousand AUD | -18846.511% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | Infinity% |
| Amplia Therapeutics Limited | - AUD | Infinity% |
| Island Pharmaceuticals Limited | -877.24 Thousand AUD | -1951.43% |
| Nyrada Inc. | - AUD | Infinity% |
| Telix Pharmaceuticals Limited | 17.31 Million AUD | 203.963% |
| Dimerix Limited | - AUD | Infinity% |
| PharmAust Limited | - AUD | Infinity% |
| Hexima Limited | - AUD | Infinity% |
| AnteoTech Limited | 221.85 Thousand AUD | 8211.516% |
| Paradigm Biopharmaceuticals Limited | - AUD | Infinity% |
| Recce Pharmaceuticals Ltd | - AUD | Infinity% |
| Avecho Biotechnology Limited | 97.11 Thousand AUD | 18630.19% |
| Actinogen Medical Limited | 108.82 Thousand AUD | 16636.001% |
| Immuron Limited | 1.58 Million AUD | 1235.673% |
| Argenica Therapeutics Limited | - AUD | Infinity% |